Resume Preparation Tips for Clinical Trial Jobs

Undoubtedly, resume is the most important tool in any job search. Most often, your resume will be your first introduction medium to the hiring managers. You may wonder what your resume could do. Here is the answer for you - Your resume would:

- Provide the hiring manager enough information for considering you for a one-on-one interview

- Supplement all the information that is included in your online profile

- Focus on your skills, experience and expertise

- Demonstrate both your writing as well as communication skills

Hence, it is important that you take your time for developing a good resume that would best showcase your skills and experience. (1)

This post would help you writing a resume for clinical trial jobs. Remember to use your CV to demonstrate that you are the ideal candidate for the particular job position.

Before going to resume preparation tips, know the common mistakes you could potentially commit while developing your resume.

If you have sent out several resumes and didn't get any responses from the recruiters, it's time for modifying your approach. Most often, recruiters would take just 10 seconds or less for scanning a resume. Hence, making proper organization of your CV is more essential. In order to make a proper organization, you must learn about the common mistakes first:

- Avoid using generic resume language. Remember that, if several other applicants are saying the exact same thing on their CV, then, your way is too generic. I would suggest you to focus on the items that are peculiar and could stand out from the recruiters.

- Another common mistake you could make is leaving out any measurable information on your CV. Like any other field, in clinical trials employment also, you must be able to include the measurable results.

- Use the space on your resume wisely. You should not clog your resume with long sentences or paragraphs. As mentioned above, recruiters are just taking seconds to read out your resumes and this makes it important to use bullet points and concise short sentences. (2)

Now, you know what mistakes you could make. Develop your resume for clinical trial jobs by making use of the following resume preparation tips:

Developing Resume for Clinical Trials Jobs:

When starting to develop your resume, please be sure to make a list of your past as well as present experiences and skills. Then, select from this list only the information that is pertinent for your resume and for the job you are applying. As a next step, you should elaborate on this list by coming up with short and concise description of each and every experience and skill. I would suggest you to start each phrase with action verb. Now, organize your resume in an effective format by keeping the most critical information at the beginning of your resume. (1)

If you are wondering how to structure your resume and what to include in it, here is what you are looking for:

Contact Details:

When you are writing your contact details, make sure they are easy to spot. You must enter the contact details at the top of the 1st page of your resume. You must include:

- Name

- Home address

- E-mail address

- Telephone number

Summary:

The summary part of your resume should be different for each of the job posting you apply for. This is because; each employer's requirements as well as the terminology would vary even for the most similar jobs.

For the purpose of figuring out what you should include in the summary, check the job description properly. Then, carry out a basic research on the web and check the employer's website for picking out the most essential qualifications they are looking for. Whenever you are writing your summary, you must focus on showing that you have the skills and attributes required by the employer.

Education Details:

In this section, you must detail all the educational institutions at which you have studied. While entering these details, make sure to include the attendance dates. And yes, place them in chronological order with the recent ones first. You may include any pharmaceutical modules, projects and/or dissertation works that are relevant to the job you are applying.

Working Experience Details:

Similar to the education details section, here also you have to list your most recent experience first. By this way, the recruiter would find it easy to see whether you have the right experience and if it is recent. Place all the other jobs after the current one in reverse chronological order. Here, you must include the following details:

- Name of the employer

- Job Title

- Responsibilities

- Achievements

Interests:

The recruiters will be interested in activities that have developed your leadership as well as team-working skills. Hence, make sure you enter the right ones on this section. In addition, you must mention any volunteering activity you have done.

References:

It is the best practice to mention two employer references:

- One from the most recent employer

- Other: either from the recent employer or from your study place

You must include:

- Address

- Telephone number

- E-mail address

Before putting the references in your resume, you must ask the concerned person (whose details you are entering) whether it is okay to mention him/her as your references.

Availability:

Yes, this is important! It is always a good idea to keep the employer informed about the notice period required by your current employer. (3), (4)

Some Additional Tips:

In order to come up with a good professional resume, you may use the additional tips below:

- Exclude any personal data like:

- Age

- Religion

- Personal photographs

- Family status

- Avoid using any abbreviations or acronyms unless and until you are sure that the reader is familiar with the terms

- Have your resume proofread by other people for correct spelling and grammar

- Make sure that your resume is easy on the eye. Make it to a maximum of two A4 pages

- Do not repeat anything. This would be like you have nothing much to tell!

CLINICAL TRIAL:OPPORTUNITES IN INDIA

This article has been reproduced herein from:         

clinical-trials-growing-opportunities-indiaTop of Form

Clinical Trials: Growing Opportunities for India

The US$65-billion (in 2005), global R&D pie is expected to grow to US$l00-billion by 2010. If India secures even a small share of this, it could grow 2-billion business.

Thus, pharmaceutical R&D, whether outsourcing or indigenous, is likely to emerge as a multi­billion dollar industry, including contract research and manufacturing, clinical trials, etc.

Indian clinical trials market in 2006 was US$ 140million and is growing at a CAGR of 40% for the last 3 years. India is fast emerging as a favoured destination for clinical trials outsourcing, in view of the country's advantages like large pool of patients, faster patient recruitment, well trained English speaking physicians and IPR (Intellectual property rights) protection, besides lower labour costs. Over 100 pharmaceutical companies, including big multinationals such as Pfizer and Merck, are currently outsourcing clinical trials in the country. Also, there is an increased awareness regarding ICH-GCP (International Conference on Harmonisation - Good Clinical Practice) guidelines for conduct of clinical research. Besides, India's inherent advantage in IT skills helped in outsourcing of high-end activities like data management.

The new drug discovery is a complex process. It involves screening of around 10,000 compounds over a period of 8-10 years before a new drug discovery is successful. It also involves huge investment to the tune of almost US$1-billion. The major cost in the drug discovery process is the clinical trials [1,2].

India is uniquely placed to undertake clinical trials, due to the following reasons:

1.Very large population base available;

2.Diverse ethnic groups available;

3.Well equipped hospitals;

4.The law, including on ethics, is in place;

5.The expertise has been developed; and

6.Most importantly, the cost is substantially lower than in the West.

In spite of the above, out of the global clinical market US$50-billion, India's share is as yet only US$100-million.

Phase I trials

This stage involves introduction of a new drug into healthy humans, to determine the metabolic and pharmacological actions of the drug, its side-effects and effectiveness. The trial evaluates drug metabolism, structure activity relationships and the mechanism of action in human. The number of subjects is typically from 20 to 50.

Phase II trials

These are controlled clinical studies for obtaining preliminary data on the effectiveness of the drug for subjects with the disease. The objective is to determine the short-term side­-effects and risks of using the drug. The number of subjects runs into several hundreds.

Phase III trials

This phase of the trial is carried out with the aim of gathering additional information about the effectiveness and safety of the drug. It provides a basis for extrapolating the results to the general population and putting that information on the label. The number of subjects ranges from several hundreds to several thousands. If the cost of new drug discovery is to be reduced, it is imperative that clinical trials are carried out effectively at a lower cost. This is where India is uniquely placed.

Indian clinical scenario

80 Indian hospitals are presently involved in clinical trials. This figure is likely to go up to 14,000 and will mean an involvement of 5 lakhs doctors, 7 lakhs bed's, 17,000 medical graduates in 160 medical colleges.

While India has many advantages for carrying out the clinical trial work meeting the stringent requirements of the west, there is competition from other countries (Table 2),

As can be seen, while India is rated high for its available patient pool, it scores average in comfort level of sponsors. In spite of competition, India is still cost competitive (Table 3).

New drug discovery is a complex process, involving screening of 10,000 compounds over a 8-10 year period and costs about US$1-billion before a new drug is successfully inducted into the market.

The major cost in drug discovery are in the Phase I, II & III clinical trials and India is uniquely placed in carrying them out due to various advantages, including substantial lower cost.

Cost-savings are a significant draw card for many pharmaceutical companies when deciding to outsource clinical research to countries in emerging markets such as India.

In the last 10 years, skyrocketing costs of R&D have led to a growth explosion in the clinical services industry as pharma companies scramble to cut costs [2,3].

CROs in India

1.Clinigene

2.Dr Reddy's Laboratories Limited

3.GlaxoSmithKline

4.Lupin Limited

5.Novartis

6.Pfizer Limited

7.Ranbaxy Laboratories Limited

8.Torrent Pharmaceuticals Limited

9.Vimta Labs Limited

10.Zydus Cadila

11. Asian Clinical Trials Limited

12.Bioserve Clinical Research Pvt. Ltd.

13.Clininvent Research Pvt. Ltd.

14.Clintec International

15. Eli Lilly and Company (India) Pvt. Ltd

16.Igate Clinical Research International

17.Intas Pharmaceuticals

18.Johnson& Johnson, India

19.Lambda Therapeutic Research Ltd

20.Lotus Labs Pvt. Ltd.

21.Matrix Laboratories Ltd.

22.Merck Limited

23.Novo Nordisk India Private Ltd.

24.Pharmanet

25.Quintiles Research (India) Private Limited

26.Reliance Clinical Research Services

27.Roche India Ltd.

28.Sanofi-Aventis (Aventis Pharma Limited)

29.Siro Clinpharm Pvt Ltd

30.SRL Ranbaxy

31.Sristek

32.Synchron Research Pvt. Ltd

Table 1: Success Rate in New Drug Discovery

Activity

Drug

screening

Preclinical

testing

Phase I

Phase II

Phase III

Market

launch

Probability of success

High risk of failure

Low risk of failure

Number of

candidates

5000

250

20

16

9

5

Probability

of entering

next phase

5%

8%

79%

58%

57%

---

Source: R. Vipranarayanan & Dr. A.K. Mukerkee; Chronicle Pharmabiz

Table 2: How India Fares in Global Clinical Research

Country

Population

(Available

patent pool)

Comfort level

of sponsors

Intellectual

property/regulation

Cost

Attractiveness

India

3

2

1

3

China

3

1

1

3

Eastern

Europe

1.5

2

2

2

US

1

3

3

1

Ratings: 1 = Low; 2 = Medium; 3 = High;

Source: 2005 study by US consultancy Proximare. Source: Business Week

Source: Pharmabiz, Cygnus Research

Table 3: Cost Competitiveness of Indian R&D

Phase

US Costs

Indian Costs

Phase I

US$ 20 million

<50% of US cost

Phase II

US$ 50 million

<60% of US cost

Phase III

US$ 100 million

<60% of US cost

Source: Pharmabiz, Cygnus Research

Table 4: Drug Discovery Pipeline of Indian Pharma sector

Company

Pre-clinical

Phase I

Phase II

Ranbaxy

5

3

2

Dr Reddy's

5

2

1

Wockhardt

-

-

1

Nicholas Piramal

-

-

1

Lupin

-

-

2

Orchid

2

1

-

Torrent

19

-

-

Glenmark

1

1

-

Dabur

29

1

1

Total

64

12

4

Source: India Brand Equity Foundation

The average cost of running a US-based clinical trial per patient is $5,404 for Phase I, $6,538 for Phase II and $7,635 for Phase III clinical trials. According to an analysis last year by Rabo India Finance, conducting a clinical trial in a lower-cost destination such as India , for example, can cost up to 60 per cent less than in the US. However, while quickly gaining momentum, India 's much hyped clinical research industry is still yet to really take off.

A report by analysts at McKinsey estimated that clinical research in India will be a $l billion (€800,000million) industry by 2010, although many analysts expect it will be closer to half that. To make India a preferred destination for drug testing finance minister has proposed to exempt clinic trial of new drugs from service tax in the Budget for the year 2007-08. Also, total exemption from service tax is being provided to technical testing and analysis for testing of new drugs, vaccines and herbal remedies, on human participants by a CRG (Clinical Reference Group) approved to conduct clinical trials by the Drugs Controller General of India.

It is a well-known fact that the world is looking at India as a clinical trial destination of choice. However, is India capable of handling large, complex clinical trials? India must pay immediate attention to handle large clinical trial projects effectively and to sustain a steady growth in the clinical trials market.

There is a large influx of clinical trials from across the globe heading towards India . Major pharmaceutical companies and global Contract Research Organizations (CROs) are expanding staff and business activity in India . In this situation, it is mandatory for India to tackle issues to sustain in the industry keep other competing countries at edge. A recently held conference on Clinical Research and Development in India held by the Institute of Clinical Research in association with DST, has highlighted following issues for the Indian attention.

Infrastructure:

Creating large-scale exclusive clinical trial facilities in India are a must. There is a need for hospitals to create special beds for clinical trials. Research institutions and pharmaceutical companies should establish clinical trial centers that do not overlap with the existing R&D facilities.

Manpower:

There is an acute manpower attrition in India. Qualified and experienced clinical trial investigators are the need of the hour. Experienced investigators who can take decisions in adverse situations have to be strengthened. According to an estimate it presently requires about 4,000 experienced Principals Investigators for major trials. There is a requirement for experienced nurses, biostatisticians, researchers and coordinators in every clinical trial, and India must train the manpower available in these areas to suit clinical trial evaluation. India has a crunch in auditors, who can audit the effectiveness of a clinical trial.

Data Management:

Effective data collection, storage and maintenance need to be strategically adapted in India . Electronic data storage and analysis need could help streamline some cumbersome process and would also save significant time.

Regulatory Compliance and Ethical Issues:

Although, the Indian Government has revised the ethical guidelines for clinical trials in 2007, CROs mllst practice and follow the guidelines diligently. A number of such isslles are bogging down on clinical trials industry in India . It is essential for the government to work in coordination with CROs, regulatory bodies and patients to help India gain the earmark as the best destination for clinical trials [1-3].

References:

1.Chemical weekly, April 17, 2007, p. 1985-87

2.Budget Speech, 2007-08

3.Conference on Clinical Research and Development in India, April 14-15, 2007, Bangalore

MNC & Indian Pharmacos in Clinical Research

1.Abbott, Mumbai

2.Chiron, Mumbai

3.Astra Zeneca Pharma India Ltd, Bangalore

4.Astra Zeneca Foundation, Bangalore

5.AventisPasteur, Delhi

6.Pfizer Ltd, Mumbai

7.Pfizer Biometrics, Mumbai

8.Altana(Zydus), Mumbai

9.Elly Lilly, Delhi

10.Boston Scientific, Delhi

11.Hospira, Delhi

12.Merck, Delhi

13.Sanofi Aventis Syntho Lab, Mumbai

14.GSK, Glaxo SmithKline Pharmaceuticals Ltd, Mumbai

15.Novartis International Clinical Development Center, Mumbai

16.Novartis Pharma, Mumbai

17.Roche, Mumbai

18.Sandoz, Mumbai

19.Wyeth, Mumbai

20.BMS, Mumbai

21.Novo Nordisk, Bangalore

22.Lundbeck, Bangalore

23.Eisai Pharmaceuticals, Mumbai

24.LG Life Sciences, Delhi

25.Bayer, Mumbai

26.GE, Delhi

27.Johnson & Johnson, Jansenn Cilag, Mumbai

28.Cordi Baxter, Delhi

29.BD Biosciences, Delhi

30.Bharat Biotech, Hyderabad

31.Bharat Serum, Mumbai

32.Cadila Pharmaceuticals

33.Cipla, Mumbai

34.Emcure, Pune

35.Fulford India Mumbai

36.Indus Biotherapeutics, Ahmedabad

37.IPCA, Mumbai

38.Shreya Biotech, Pune

39.Shantha BiotechnicsPvt. Ltd. Hyderabad

40.Sun Pharma, Mumbai

41.Torrent Pharmaceutical Ltd, Gandhi nagar

42.USV Ltd. Mumbai

43.Wockhardt, Mumbai

44.Zydus Cadilla, Ahmedabad

45.Biocon, Bangalore

46.Cadila Pharmaceuticals, Ahmedabad

47.Intas Pharmaceuticals Ltd., Ahmedabad

48.Glenmark Pharmaceuticals Ltd., Mumbai

49.Himalaya Drugs ,Bangalore

50.Lupin Ltd., Pune

51.Nicholas Piramal,Mumbai

52.Panacea Biotech, Delhi

53.Ranbaxy Research Laboratories, Delhi

54.Ranbaxy Research Laboratories, Gurgaon

55.Serum Institute of India, Pune

56.Torrent, Ahmedabad

List of Major CROs

» Quintiles Ahmadabad/Bangalore

» Synchron Ahmadabad/Bangalore

» Lambda Ahmadabad

» Siro Clinpharm Mumbai

» I-Gate Mumbai

» Reliance Clinical Services Mumbai

» PPD Mumbai

» Onmnicare Bangalore

» ICON Bangalore

» Clin Trac Bangalore

» PharmaNet Bangalore

» Pharm-Olam Bangalore

» Lotus Labs Bangalore

» Vimta Hyderabad

» GVK Hyderabad

» BioServe Clinical Research Hyderabad

» Apothecaries Delhi

» Kendle Delhi/Gurgaon

» Bioassay Baroda

» Clinworld Bangalore

» Perinclinical Mumbai

» Quest Life Sciences  

» Micro Therapeutic Research Labs Private Limited Chennai

List of Pharmacovigilance Companies in India

List of Pharmacovigilance Companies in India

HYDERABAD: 12

1. NOVARTIS

2. PARAXEL

3. MAKROCARE

4. MAHINDRA SATYAMBSG

5. DR REDDY’S

6. AUROBINDO

7. SRISTEK

8. SHANTHA BIOTECHNICS

9. NEKTAR THERAPEUTICS

10. VIMTA LABS

11. BIOLOGICAL E. LTD

12. MEDHIMALAYAS

BENGALURU: 14

13. QUINTILES

14. SYNOWLEDGE PV SERVICES

15. BIOCON

16. ACCENTURE

17. ASTRAZENECA

18. BLUEFISH

19. SCIFORMIX/STRIDES ACROLABS

20. MMS-HOLDING

21. NORWICH CLINICAL SERVICES

22. HCL

23. OMNICARE CLINICAL RESEARCH

24. MICRO LABS

25. ECRON ACUNOVA

26. G7 INFOTECH

MUMBAI: 11

27. COGNIZANT

28. TCS

29. SIRO CLINPHARM

30. MEDPACE

31. SCIFORMIX

32. PPD

33. SYMOGEN

34. IPCA LABORATORIES

34. RATIOPHARM

35. DIAGNOSEARCH

36. UNIJULES (NAG PUR)

PUNE: 2

37. I 3 GLOBAL DRUG SAFETY

38. SCIFORMIX

CHENNAI: 4

39. ICON

40. ACCENTURE

41. RX MD

42. TAKE SOLUTIONS

DELHI: 5

43. JUBILIANT-BIOSYS

44. APCER, DELHI

45. WIPRO

46. I GATE PATNI COMPUTERS

47. APC PHARMA

GURGOAN: 5

48. KINAPSE

49. MSD (MERCK)

50. I 3 GLOBAL DRUG SAFETY

51. GVK

52. WNS

AHMEDABAD: 2

53. LAMBDA

54. INC RESEARCH

CHANDIGARH: 1

55. QUANTUM SOLUTIONS

What to Do If Unsuccessful in Exams

It is always difficult to forecast the result of the exams; it does not matter whether you are in school or college. It is because exams are scariest part of student life but exams take out the finest ones, predictably or unpredictably. But for some student’s exams results can be a mental disaster and they cannot handle the mental stress of getting failed. Failing is the most disturbing and shocking experience. Only way to manage the mental stress of failure is to talk to the people. Discuss the matter with your family, friends and your mentor who can suggest you with a better approach for future career aspects. Keep in mind that failing in the exam does not mean that it is the end of your life or career opportunities. It is a phase if life which you have to pass through in life sooner or later. We fall to rise again and to rise above failure. Failure gives you strength and makes you stronger. Failures make you understand what it means to fail which was beyond your expectations.

It is always difficult to forecast the result of the exams; it does not matter whether you are in school or college. It is because exams are scariest part of student life but exams take out the finest ones, predictably or unpredictably......

Students worry so much about their failures because they feel that just because of this single failure they are not going to get their dream job or university (college), which is absolutely wrong. Do not let your failures hinder your performance or achieving anything in life. These failures must not convince you that you cannot achieve your goals. Failing in exam does not mean that you are less than anyone who has performed better than you exams.

How to handle such scenario- Advices for students

• The students should: Consider all possible priorities, resources and problems and Follow a stabilized routine at home.
• Should not envision extreme consequences and worst circumstances. Should not amplify failure or degrade self.
• Stay connected with the teachers or counselors when feeling low or worried or disinterested.
• Cultivate alternative managing strategies and de -emphasis from the pain.
• Relax your mind. Be positive and hope for the best.
• Talk to family and friends. Stop worrying. Outcome is not the final influential factor.
• Go for the options available. Find out and update with wide and diverse choices. Your decision should not be influenced by others.be true to yourself. Don’t forget your strengths and your capabilities and your own choices.

Steps required to study with concentration:

1. Eliminate Interruptions: choose a place to study which is interruption free. Where you have lowest noise pollution, your study place is the last place to be interrupted by the guests
2. You need to utilize the time of the day which suits you the best, in which you feel fresh and can easily grasp whatever you study. Researchers have proved that 60 minutes study at morning is equivalent to 90 minutes study at night.
3. You need to focus on the ongoing task and it must be given the utmost priority. We should try and keep ourselves away from the distractions. For instance, you must study for the time you had previously decided without peeping into your notifications on your Facebook account.
4. Set Goals: decide how long you are going to study and what subjects you need to complete before you leave your study table. Always stick to the planned goals.
5. Positive attitude: keep no phrase in dictionary like “I cannot do it” or it cannot be achieved.
6. Rest/Stretch time: take breaks to walk around. Short walks pump blood supply to your brains which eventually increases supply of oxygen to your mind and increases understanding and concentration.
7. Changing the subject: Keep changing the subjects you study. Do not study the same subject for long hours. If you change subject then you absorbs more points than keep studying the same subject and getting fed up of that.
8. Reward yourself: give yourself small treats for achieving the goal. It will keep you happy and fulfilled

if you set your goals ridiculously high and its a failure, you will fail above everyone elses success ― James Cameron